Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Eastnine | EAST | 21. nov 2024 | 42.79 | +1.88 |
EasyFill B | EASYB | 21. nov 2024 | 0.17 | +4.17 |
EatGood | EATG | 21. nov 2024 | 0.44 | +0.68 |
eBlitz Group | EBLITZ | 21. nov 2024 | 1.20 | 0.00 |
Ecoclime Group B | ECCB | 21. nov 2024 | 1.92 | -4.25 |
ECOMB | ECOM | 21. nov 2024 | 0.12 | +8.22 |
EcoRub B | ECOB | 21. nov 2024 | 0.13 | +4.72 |
Edyoutec AB | EDYOU | 21. nov 2024 | 0.95 | -6.42 |
eEducation Albert | ALBERT | 21. nov 2024 | 3.70 | +1.09 |
Eevia Health | EEVIA | 21. nov 2024 | 0.25 | 0.00 |
Effnetplattformen Holding | EFFH | 21. nov 2024 | 4.20 | 0.00 |
Egetis Therapeutics | EGTX | 21. nov 2024 | 5.40 | -0.55 |
Elanders B | ELANB | 21. nov 2024 | 87.80 | -0.34 |
Electrolux A | ELUXA | 21. nov 2024 | 97.00 | -3.00 |
Electrolux B | ELUXB | 21. nov 2024 | 79.98 | -1.62 |
Electrolux Professional B | EPROB | 21. nov 2024 | 64.00 | +1.27 |
Elekta B | EKTAB | 21. nov 2024 | 61.80 | -0.48 |
Elicera Therapeutics | ELIC | 21. nov 2024 | 1.76 | -1.40 |
Ellen | ELN | 21. nov 2024 | 1.06 | 0.00 |
Ellwee | ELLWEE | 21. nov 2024 | 4.13 | +2.99 |
Elmera Group | ELMRAO | 21. nov 2024 | 38.05 | -2.69 |
Elon AB (publ) | ELON | 21. nov 2024 | 24.60 | -2.38 |
Eltel | ELTEL | 21. nov 2024 | 6.54 | -2.39 |
Embark Group | EMB | 21. nov 2024 | 0.44 | -0.89 |
EmbeddedArt Group AB (publ) | EMART | 21. nov 2024 | 7.95 | +7.87 |
Embellence Group | EMBELL | 21. nov 2024 | 30.40 | 0.00 |
Embracer Group B | EMBRACB | 21. nov 2024 | 27.50 | -3.51 |
Emilshus | EMILPREF | 21. nov 2024 | 29.90 | -1.32 |
Emilshus B | EMILB | 21. nov 2024 | 43.80 | -0.45 |
Enad Global 7 | EG7 | 21. nov 2024 | 13.00 | +1.48 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.